KL-6 as a serum marker for amiodarone-induced pulmonary toxicity

Internal Medicine

Volumn 39, Issue 12, 2000, Pages 1004-1005

  Kohno, N ^a   Yokoyama, A ^a   Kondo, K ^a  

^a EHIME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Interstitial pneumonia; MUC1

Indexed keywords

AMIODARONE; GLYCOPROTEIN; GLYCOPROTEIN KL 6; LACTATE DEHYDROGENASE; MARKER; UNCLASSIFIED DRUG;

EDITORIAL; HEART ARRHYTHMIA; HUMAN; INTERSTITIAL PNEUMONIA; LUNG TOXICITY;

EID: 0034524235     PISSN: 09182918     EISSN: None     Source Type: Journal    
DOI: 10.2169/internalmedicine.39.1004     Document Type: Editorial

References (11)

1. Amiodarone. Reevaluation of an old drug
2. Pulmonary complications of amiodarone toxicity
3. Amiodarone-induced pulmonary toxicity. Predisposing factors, clinical symptoms and treatment
4. New serum indicator of interstitial pneumonitis activity: Sialylated carbohydrate amtigen KL-6
5. KL-6: A new serum marker for interstitial pneumonia
6. Comparative evaluation of sialylated carbohydrate antigens, KL-6, CA19-9 and SLX as serum markers for interstitial pneumonia
7. Circulating antigen KL-6 and lactate dehydrogenase for monitoring irradiated patients with lung cancer
8. Serum KL-6 for the evaluation of active pneumonitis in pulmonary sarcoidosis
9. Evaluation of serum KL-6 levels in patients with pulmonary tuberculosis
10. Diagnostic usefulness of KL-6 measurements in patients with pulmonary complications after administration of amiodarone
11. Serum KL-6 as a possible marker for amiodarone-induced pulmonary toxicity